Novo Nordisk Recalls Insulin Pens All Over Europe

By Juan Carlos Rodriguez (October 25, 2013, 3:26 PM EDT) -- Novo Nordisk A/S said Friday it's recalling certain batches of NovoMix 30 FlexPen, a prefilled insulin product, in Europe because they don't meet the specifications for insulin strength, which could lead to the patient's blood sugar level becoming higher or lower than expected.

The company is recalling some NovoMix 30 FlexPens in Austria, Belgium, the Czech Republic, Denmark, France, Germany, Iceland, Luxemburg, the Netherlands, Norway and Slovakia. In Ireland and the U.K., three batches of NovoMix 30 Penfill are being recalled. The company said other countries in the European Union may have received the affected batches through parallel distribution. The pens...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!